DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS 
The 2025 ACC/AHA hypertension guideline, developed in collaboration with 11 professional societies, provides evidence-based recommendations for hypertension prevention, detection, evaluation and management in adults. The guideline emphasizes lifestyle modifications, early kidney disease detection, and community involvement to improve cardiovascular outcomes.
⚕️ Key Clinical Considerations ⚕️
- The PREVENT risk calculator, validated in 3.2 million diverse patients, improves cardiovascular risk prediction.
- Revised lifestyle recommendations: ≤2,300 mg sodium/day, alcohol moderation, 75-150 min/week exercise.
- Stage 1 HTN low-risk patients: lifestyle therapy first, consider medication if BP>130/80 after 3-6 months.
- Precise in-office and out-of-office BP measurement critical for treatment decisions.
- Initial evaluation should include urine albumin-to-creatinine ratio to detect kidney disease early.
🎯 Clinical Practice Impact 🎯
- Patient Communication: Provide verbal and written BP results, discuss lifestyle and medication options.
- Practice Integration: Train staff on proper BP measurement, partner with community for screenings.
- Risk Management: Screen all patients for kidney disease, consider GLP-1 agents for those with obesity.
- Action Items: Implement PREVENT calculator, create HTN protocol leveraging new targets and therapies.
- Health Equity: Address social determinants of health, engage multidisciplinary teams to reduce disparities.
More in Kidney Disease
